Page last updated: 2024-08-24

mazapertine succinate and 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide

mazapertine succinate has been researched along with 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baldwin, RM; Brenner, L; Charney, DS; Hoffer, PB; Innis, RB; Krystal, JH; Mochoviak, S; Offord, SJ; Seibyl, JP; Zea-Ponce, Y	1

Other Studies

1 other study(ies) available for mazapertine succinate and 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide

Article	Year
Continuous intravenous infusion of iodine-123-IBZM for SPECT determination of human brain dopamine receptor occupancy by antipsychotic agent RWJ-37796. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:1 Topics: Adult; Antipsychotic Agents; Benzamides; Brain; Contrast Media; Corpus Striatum; Dopamine Antagonists; Dose-Response Relationship, Drug; Feasibility Studies; Humans; Infusions, Intravenous; Iodine Radioisotopes; Male; Piperazines; Pyrrolidines; Receptors, Dopamine; Receptors, Dopamine D2; Time Factors; Tomography, Emission-Computed, Single-Photon	1996

Article

Year

Continuous intravenous infusion of iodine-123-IBZM for SPECT determination of human brain dopamine receptor occupancy by antipsychotic agent RWJ-37796.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:1

Topics: Adult; Antipsychotic Agents; Benzamides; Brain; Contrast Media; Corpus Striatum; Dopamine Antagonists; Dose-Response Relationship, Drug; Feasibility Studies; Humans; Infusions, Intravenous; Iodine Radioisotopes; Male; Piperazines; Pyrrolidines; Receptors, Dopamine; Receptors, Dopamine D2; Time Factors; Tomography, Emission-Computed, Single-Photon

1996